جستجوی استاد راهنمای دانشگاهی

• Immunology
• Genomics
• Multiomics Analysis
• +۳ مورد دیگر

Calliope Dendrou is an Associate Professor in Clinical Pathology and Inflammation at the Kennedy Institute of Rheumatology (KIR), University of Oxford, leading the Immune Disease Multiomics Laboratory. She previously held a Wellcome & Royal Society Sir Henry Dale Fellowship at the University of Oxford’s Centre for Human Genetics before joining KIR in 2023. Her research focuses on immune disease mechanisms using multiomics approaches, including genomic profiling to identify therapeutic targets across tissues and immune-mediated diseases. She co-leads large-scale projects like the Oxford-J&J Cartography Consortium and the Chan Zuckerberg Initiative’s LEGACY Network, and teaches on the MSc in Genomic Medicine program. Educational Background: BSc (Biology, Imperial College London, 2005; Forbes Memorial Medal Winner); PhD in Infection & Immunity (University of Cambridge, 2010). Postdoctoral training at the Weatherall Institute of Molecular Medicine under Prof. Lars Fugger. Research interests include immunogenetics, cytokine signaling pathways, drug repositioning, and cross-disease pathophysiology. Her work integrates single-cell and spatial transcriptomics to dissect immune-cell interactions in diseases like rheumatoid arthritis, inflammatory bowel disease, and celiac disease. Recent articles highlight her contributions to understanding vaccine adjuvant responses, Th17 cell roles in spondyloarthritis, and immune-epithelial networks in celiac disease. Collaborations emphasize multi-omic data analysis (e.g., Panpipes pipeline) and translational studies toward precision medicine. Awards: Forbes Memorial Medal (BSc), Wellcome & Royal Society Sir Henry Dale Fellowship. Leadership roles include Equality, Diversity, and Inclusion Champion and 'Single-Cell & Spatial Omics for Precision Medicine' Module Lead. Lab & Teams: Immune Disease Multiomics Lab at KIR. Active in collaborative initiatives such as the LEGACY Network, focusing on large-scale immune profiling in ancestrally diverse populations.

• Perinatal Brain Injury
• Neonatal Neuroscience
• Maternal Nutrition
• +۵ مورد دیگر

Carina Mallard is Professor of Experimental Perinatal Brain Injury Research and Pro-Vice-Chancellor at the University of Gothenburg since July 2023, where she oversees research infrastructure and chairs the Research Board. She previously served as Deputy Vice-Chancellor (2021–2023) and Head of Core Facilities (2018–2021). Her academic career began with a Physiology degree from Lund University and a PhD in Pediatrics at the University of Auckland (1995), followed by a professorship appointment in 2006. Her research focuses on perinatal brain injury , particularly in premature infants , investigating neuroinflammatory mechanisms maternal dietary interventions neurovascular unit dynamics microglia activation long-term consequences of maternal obesity . Recent publications highlight her work on neonatal rodent models , transcriptomic profiling , and anti-inflammatory therapies . Key themes include RNA degradation , mitochondrial protection , and immune-neurovascular interactions . She has supervised 20 doctoral students since 2004 and collaborates internationally with institutions like King's College London. Contact details include two institutional emails and physical addresses across Gothenburg's biomedical campuses. Her leadership roles span research strategy, doctoral education, and EU-level scientific initiatives.

Christopher M. Overallمشاهده پروفایل

استاد

• Protease Proteomics
• Systems Biology
• Degradomics
• +۶ مورد دیگر

Christopher M. Overall is a Full Professor at the University of British Columbia in the Faculty of Dentistry, Department of Oral Biological and Medical Sciences . He is also a Principal Scientist at the Centre for Blood Research and holds associate memberships in UBC's Biochemistry & Molecular Biology , Obstetrics and Gynecology , and Bioinformatics Graduate Program departments. As a Canada Research Chair Laureate , he pioneered the field of degradomics to study proteases in vivo. B.D.S., University of Adelaide Ph.D., University of Toronto Postdoctoral Fellowship, UBC (with Nobel Laureate Michael Smith) Dr. Overall’s research focuses on protease proteomics and systems biology , particularly degradomics to analyze protease substrates in diseases like COVID-19 and immunodeficiency . His work on matrix metalloproteinases has revealed new therapeutic strategies for inflammatory diseases and cancer . His 15 most recent articles (2015–2008) demonstrate expertise in TAILS proteomics , protein terminomics , and protease network analysis with applications in arthritis , antiviral immunity , and precision medicine . Scientific Awards 2022 Helmut Holzer Award 2018 Royal Society of Canada Fellow 2014 Tony Pawson Canadian Proteomics Award 2013 IADR Distinguished Scientist Award Dr. Overall has mentored 61 trainees , including 9 full professors with department chairs, and received the UBC John McNeill Mentorship Award (2023). He leads the HUPO Chromosome-centric Human Proteome Project and consults for Genentech and Novartis .

Waldemar Kolanusمشاهده پروفایل

استاد

• Molecular Immunology
• Cell Signaling
• Signal Transduction Pathways
• +۴ مورد دیگر

Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788

Martin Burkeمشاهده پروفایل

استاد

• Organic Chemistry
• Small-Molecule Synthesis
• Molecular Prosthetics
• +۷ مورد دیگر

Martin Burke is the May and Ving Lee Professor for Chemical Innovation and Professor of Chemistry at the University of Illinois Urbana-Champaign , with additional appointments in Biochemistry, Biomedical & Translational Sciences, and multiple campus institutes including the Beckman Institute and the Carl R. Woese Institute for Genomic Biology. Education B.S. Johns Hopkins University , 1998 Ph.D. Harvard University , 2003 M.D. Harvard Medical School , 2003 Research Interests Burke’s program centers on molecular prosthetics : the design, synthesis and application of small molecules that replicate or replace missing or dysfunctional proteins. His group pioneered iterative cross-coupling (ICC) using MIDA-protected haloboronic acids to automate the construction of complex natural products and function-oriented small molecules. Current projects target ion-channel replacement in cystic fibrosis, iron-transport restoration in anemia, and non-toxic antifungals that overcome drug resistance. Scientific Awards & Honors National Academy of Medicine (2021) AAAS Fellow (2021) ASCI Member (2021) iCON Award (2019) Mukaiyama Award, Japan (2019) ACS Nobel Laureate Award for Graduate Education (2017) Thieme-IUPAC Prize in Synthetic Organic Chemistry (2014) Elias J. Corey Award (2013) Arthur C. Cope Scholar Award (2011) Research Output & Impact Burke has authored >120 peer-reviewed articles, >30 patents, and his work has been cited >20,000 times. High-impact publications in Nature , Science , and Angewandte Chemie have advanced automated synthesis, molecular prosthetics, and cystic fibrosis therapeutics. Laboratory & Training The Burke Laboratories house a multidisciplinary team of graduate students, post-doctoral researchers, and physician-scientists developing next-generation molecular prosthetics. The group is supported by NIH, NSF, private foundations, and industry partnerships aimed at democratizing molecular innovation.

Michael Wilczekمشاهده پروفایل

استاد آموزشی

• Virology
• Bioinformatics
• Molecular Epidemiology
• +۳ مورد دیگر

Dr. Michael Wilczek is Assistant Teaching Professor in Biotechnology/Bioinformatics at Northeastern University's Roux Institute. His research bridges virology, bioinformatics, and educational innovation, with particular focus on JC polyomavirus pathogenesis and graduate education reform. Key research domains include: Molecular mechanisms of viral infections Bioinformatic analysis of host-pathogen interactions Observational health and real-world evidence Evidence-based graduate education His publication record demonstrates: Expertise in JC polyomavirus cellular pathways Innovative applications of machine learning in virology High-throughput drug screening methodologies Health disparities research in aging populations

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۱۲ مورد دیگر

Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.

Debra Moore-Hillمشاهده پروفایل

دانشیار

• Epilepsy
• Clinical Neurophysiology
• ICU EEG Monitoring
• +۶ مورد دیگر

Debra Moore-Hill is an Associate Professor in the Department of Neurology at the Medical College of Georgia, Augusta University. She serves as Section Chief of Epilepsy and Vice Chair for Neurology Education, playing a pivotal role in clinical leadership and medical education. Her work spans epilepsy care, neurophysiology, and resident training. MPH in Public Health, Augusta University, 2017 MD, Medical College of Georgia, 2007 Her research and clinical interests focus on ICU EEG monitoring, epilepsy in women of childbearing age, and epilepsy in neuro-oncology patients. She is deeply committed to curriculum development and resident education, with a strong emphasis on clinical neurophysiology and the management of intractable epilepsy. Her work also addresses health disparities in epilepsy clinical trials and innovative treatments for autoimmune encephalitis. Recent publications highlight her expertise in spreading depolarization in stroke models, NORSE treatment with VNS, and disparities in epilepsy research. Her work bridges translational neuroscience, clinical innovation, and educational excellence. Clinical Science Teaching Distinguished Faculty Award, 2024 Alpha Omega Alpha Honor Society, 2022 Exemplary Teaching Award (2022, 2018) Top percentile scorer on national residency examination, 2011 Dr. Moore-Hill is actively involved in graduate medical education, serving as Chair of the GME Cardiology Special Review Committee and member of multiple GME and institutional quality committees. She mentors students through SEEP and has led public health initiatives, including CPR training and Women in STEM outreach. Her service extends to national organizations like the American Academy of Neurology and the American Clinical Neurophysiological Society. She contributes to resident education through courses such as Neurology Clerkships, Consult Clinics, and the Osler Apprenticeship. Her leadership in the Department of Neurology Quality/OPPE and GME Housestaff in Difficulty Consult Team underscores her commitment to educational and clinical excellence.

• Microbial Biofilms
• Environmental Microbiology
• Antibiofilm Drug Development
• +۴ مورد دیگر

Staffan Kjelleberg is a Distinguished University Professor at Nanyang Technological University (NTU), Singapore, and Director of the Singapore National Biofilm Consortium (SNBC) and Singapore Centre for Environmental Life Sciences Engineering (SCELSE). He holds previous positions as Scientia Professor at the University of New South Wales (UNSW), Australia, and has led major research initiatives globally. His academic career spans over four decades, with roles including Head of School at UNSW and Professorships at the University of Gothenburg, Sweden. Education: BSc (Chemistry and Biology, 1975), PhD (Microbiology, 1981), and Docent (Microbiology, 1983) from the University of Gothenburg. He has authored over 384 journal papers with significant citations, reflecting his leadership in microbial biofilm research. Research focuses on microbial biofilms and microbiomes, addressing environmental sustainability, public health, and industrial applications. He employs an interdisciplinary approach to study biofilm community dynamics, matrix properties, and translational technologies for biofilm control. Key contributions include discoveries on quorum sensing inhibitors, biofilm dispersal mechanisms, and eDNA roles in biofilm structure. Honours include Fellowships from the Australian and American Academies of Microbiology, Web of Science Highly Cited Researcher status, and Editor roles for 15 international journals. He leads major programs like the Marine Climate Change Science initiative and has co-directed global research centers such as the Centre for Marine Bio-Innovation. Advising and grants: While specific student names are not listed, his extensive leadership in research programs indicates mentorship of numerous scholars. His work bridges fundamental and applied microbiology, impacting environmental and biomedical fields. Labs/Teams: Directs SCELSE and SNBC, co-founded the Centre for Marine Bio-Innovation, and collaborates internationally on biofilm and microbiome research.

Yu Heمشاهده پروفایل

استادیار

• Condensed Matter Physics
• Quantum Materials
• Superconductivity
• +۳ مورد دیگر

Yu He is an Assistant Professor of Applied Physics and Physics at Yale University, affiliated with the Department of Physics. His research focuses on condensed matter physics and experimental techniques such as angle-resolved photoemission spectroscopy (ARPES) and x-ray scattering to study correlated electronic systems and quantum materials. Prior to Yale, he completed a Miller Research Fellowship at UC Berkeley (2019) after earning his Ph.D. in Applied Physics from Stanford University. Key research areas include metal-to-insulator transitions, superconductivity, 2D magnetism, and solid-state quantum simulation. He has contributed to advancements in material characterization techniques, including high-resolution ARPES using tabletop lasers. His work integrates crystal synthesis, electric transport measurements, and surface decoration to explore material properties. Education: B.S. in Physics from University of Science and Technology of China (USTC); M.S. in Electrical Engineering and Ph.D. in Applied Physics from Stanford University. Research Interests: Experimental condensed matter physics, quantum materials, superconductivity, and light-matter interaction studies. His current projects aim to dissect microscopic degrees of freedom (electronic, lattice, spin) in novel materials using cutting-edge spectroscopic methods. The lab employs complementary techniques like electric transport measurements and crystal growth to characterize material properties comprehensively. Awards: Miller Research Fellow, UC Berkeley (2019) Advising & Grants: No student advisees listed. Research supported by Yale University and prior fellowships. Labs & Teams: Leads a research group at Yale focused on experimental condensed matter physics, collaborating on projects involving advanced material characterization and quantum material discovery.

Charlah Robinsonمشاهده پروفایل

استاد بالینی

• Complex fetal abnormalities
• Maternal complications
• Gestational diabetes
• +۱ مورد دیگر

Charlah Robinson, MD is a Clinical Professor at the University of California San Francisco (UCSF) School of Medicine , affiliated with the Maternal-Fetal Medicine & Reproductive Genetics division. She completed her medical education at the University of Pennsylvania , earning a B.A. in Art History (1982), M.D. in Medicine (1990), followed by an Internship and Residency in Obstetrics and Gynecology (1994) and a Fellowship in Maternal-Fetal Medicine (1996). Her clinical and research focus centers on complex fetal abnormalities and maternal complications , with expertise in gestational diabetes and hypertension in pregnancy . Her work addresses critical challenges in high-risk pregnancies, including pharmacological interventions and obstetric outcomes. While her published research includes studies on fetal positioning during labor, neonatal risks of maternal treatments, and infectious disease implications in obstetrics, no scientific awards or students are explicitly mentioned in the provided text.

Zhiwen Jonathan Zhangمشاهده پروفایل

دانشیار

• Biomolecular Engineering
• Drug Discovery
• Bioengineering
• +۴ مورد دیگر

Dr. Zhiwen Jonathan Zhang serves as Associate Professor in the Department of Bioengineering at Santa Clara University's School of Engineering since 2011, with research spanning biomolecular engineering, drug discovery, and BIOAI to combat super-bacterial infections and advance precision protein technologies. Education: Ph.D. in Chemistry and Biochemistry, University of Texas at Austin (2001) Postdoctoral Research, The Scripps Research Institute (2001-2004) His interdisciplinary research pioneers unnatural genetic codes, trM2H systems, site-specific protein cross-linking, and synthetic antibodies. Current focus includes mitochondrial peptide transport, BIOAI design, subcellular protein synthesis, and engineering bacteria for micro-plastics degradation. His lab unraveled molecular dialogues between mammalian and Gram-positive bacterial cells, enabling groundbreaking anti-infective therapies. Publication trends reveal consistent innovation in protein engineering and translational bioengineering, with recent work emphasizing sortase A applications, fluorescent peptide development, and unnatural amino acid incorporation in mammalian systems—demonstrating a trajectory from fundamental biochemistry to industry-ready biotech platforms. Dr. Zhang has mentored 7 post-doctoral researchers, 2 visiting professors, and 5 Ph.D. students while securing grants from NIH NCI R01, NSF SBIR, American Heart Association, Welch Foundation, JOINN Foundation, IBM, and SCU Internal Research. His patented "Biotech+Techbio" platform has co-founded multiple biotech ventures, including two publicly traded companies and a 2024 acquisition. His laboratory maintains active collaborations with Bay Area biotech firms and academic institutions, driving translational research through the patented Biotech+Techbio platform while advancing BIOAI-assisted enzyme discovery for micro-plastics degradation and next-generation antibacterial therapies.

Elisa Marie Hovenمشاهده پروفایل

استاد

• Criminal Law
• Criminal Procedure Law
• Corporate Criminal Law
• +۷ مورد دیگر

Prof. Dr. Elisa Marie Hoven is a professor at the Faculty of Law, University of Leipzig, specializing in German and foreign criminal law, criminal procedural law, and commercial/media criminal law. She works at Burgstraße 21, Room 1.10, Leipzig. Education: Law at Free University Berlin, Radboud University Nijmegen, and University of Cambridge Professional Background: Legal clerkship in Berlin and at the International Criminal Court; visiting roles at Berkeley, Harvard, Sydney, and others Her research focuses on: Corporate criminal law (particularly corporate sanctions) Media criminal law and digitalization (hate speech) Sentencing law reform Anti-doping legislation Animal welfare criminal law Current third-party funded projects: "Gerechte Strafzumessung" (DFG-funded, analyzing sentencing practices and proposing reforms) "Hate Speech im Internet" (funded by German Federal Ministry of Justice, interdisciplinary collaboration with media studies and sociology) Scientific awards: Habilitation award from the University of Erlangen-Nuremberg Dissertation prize from the Free University of Berlin She leads the "Legal Lab Hate Speech" and founded the national Moot Court Strafrecht. Her work spans legal education, empirical research, and public science communication.

Subash Jonnalagaddaمشاهده پروفایل

استاد

• Medicinal Chemistry
• Organic Chemistry
• Drug Development
• +۴ مورد دیگر

Subash Jonnalagadda, Ph.D., is a Professor and Department Head of Chemistry & Biochemistry at Rowan University's College of Science & Mathematics, also affiliated with the Biological & Biomedical Sciences program. He holds a B.S. from Pondicherry University, M.S. from University of Hyderabad, and Ph.D. in Organic Chemistry from Purdue University, with postdoctoral training at University of Pennsylvania and University of Minnesota. Recipient of Rowan University's Wall of Fame Teaching Award (2013, 2016) Eli Lilly International Graduate Scholar (2000-2005) Research focuses on: Medicinal Chemistry: Developing boron-based small molecules (e.g., benzoboroxoles) and betulinic acid derivatives as anti-cancer agents Biomass Valorization: Converting cellulose into chemicals like hydroxymethylfurfural for bio-based polymers Publications emphasize anti-cancer drug design, nanocarrier systems, and enzyme inhibition strategies. Advised over 50 graduate/undergraduate students, many progressing to academic and pharmaceutical careers. Collaborates with Rowan School of Osteopathic Medicine on Alzheimer's drug candidates.

• Amyloid Fibrils
• Soft Materials
• Biomaterials
• +۴ مورد دیگر

Dr. Tonghui Jin serves as a Researcher at ETH Zurich's Institute of Food, Nutrition and Health within the Department of Health Sciences and Technology. Based at the Laboratory of Food & Soft Materials (Schmelzbergstrasse 9, Zürich), her work bridges fundamental protein science with industrial applications in sustainability and healthcare. Her research centers on amyloid fibril engineering for multifunctional biomaterials, with three core thrusts: Environmental Solutions : Developing amyloid-based membranes for PFAS water remediation and amine-functionalized aerogels for CO2 capture Biomedical Innovation : Creating microneedle patches for diabetic wound healing and toxin-responsive nanovaccines against bacterial infections Advanced Materials : Engineering structural color systems from amyloid liquid crystals and superwetting functional coatings These efforts leverage protein nanofibrils' unique mechanical and catalytic properties to address global challenges in resource recovery and health. Analysis of her 2021-2025 publications reveals a strategic shift toward catalytic amyloid hybrids, with 60% of recent work focusing on CO2 conversion, lithium recovery, and enzymatic detoxification. The interdisciplinary nature spans materials chemistry, environmental engineering, and biotechnology, demonstrating consistent innovation in converting amyloid polymorphism into functional platforms. No scientific awards were documented in available sources. Dr. Jin contributes to ETH Zurich's Laboratory of Food & Soft Materials, which investigates protein-based soft matter systems for sustainable food and health applications. The lab specializes in fibrillar material assembly, with current projects targeting circular economy solutions through bio-based material design.